![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI)...
GlaxoSmithKline plc and Theravance, Inc. announced the completion of the phase III programme of...
Potency of statins linked to muscle side effects
A study from the University of California, San Diego School of Medicine, published online...
First evidence from humans on how alcohol may boost risk of cancer
Almost 30 years after discovery of a link between alcohol consumption and certain forms...
Statin therapy associated with lower risk of pancreatitis
Although some studies have suggested that use of lipid-lowering therapies may increase the risk...
Canada needs national approach to protect against drug shortages
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with...
Scientists can now block heroin, morphine addiction
In a major breakthrough, an international team of scientists has proven that addiction to...
Diabetes drugs raises risk of bladder cancer
Researchers from the Perelman School of Medicine at the University of Pennsylvania found that...
GlaxoSmithKline reaches agreement to divest majority of Classic Brands in Australia for £172m
GlaxoSmithKline plc (GSK) has reached agreement to divest the majority of its “Classic Brands”...
Boehringer Ingelheim achieves further growth in first half of 2012
The pharmaceutical company Boehringer Ingelheim has grown again in the current financial year. In...
Pfizer and AstraZeneca enter into agreement for over-the-counter Nexium
Pfizer Inc. announced that it has entered into an agreement with AstraZeneca for the...